Jim Jones Deputy Commissioner for Human Foods of FDA | Official Website
Jim Jones Deputy Commissioner for Human Foods of FDA | Official Website
This is a 53.3% decrease from the number of companies inspected in the previous quarter, when 15 companies received 15 inspections.
Most of the companies inspected at the time were involved in the Devices and Biologics sectors. The second most common type of company inspected worked in the Drugs sector.
There were six companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct its management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Amtai Medical Equipment, Inc. | Devices | 12/06/2024 | Voluntary Action Indicated (VAI) |
| Bioaesthetics Corporation | Biologics | 10/03/2024 | No Action Indicated (NAI) |
| Biomat USA, Inc. | Biologics | 10/24/2024 | No Action Indicated (NAI) |
| Carolinas Cord Blood Bank | Biologics | 11/22/2024 | No Action Indicated (NAI) |
| Jad Walters, Ph. D. | Devices | 11/07/2024 | No Action Indicated (NAI) |
| Tergus Pharma, LLC | Drugs | 12/13/2024 | No Action Indicated (NAI) |
| VA Medical Center IRB | Devices | 12/10/2024 | No Action Indicated (NAI) |
| VA Medical Center IRB | Drugs | 12/10/2024 | No Action Indicated (NAI) |
Alerts Sign-up